UCSF Cancer Center Awarded $36 Million Grant

Frank McCormick, PhD,

By Elizabeth Fernandez, UCSF The National Cancer Institute (NCI) has awarded the UC San Francisco Helen Diller Family Comprehensive Cancer Center a $36 million to support cutting-edge research programs and clinical trials over five years. The highly competitive funding, awarded in recognition of UCSF’s excellence in laboratory, clinical and population-based research, will fund administrative management and infrastructure to support efforts across the spectrum of cancers, including breast cancer, prostate cancer and pediatric cancer. The grant is the latest funding to the center, which is one of the country’s leading cancer research and clinical care centers. It is the only comprehensive cancer center in the San Francisco Bay Area. The first year’s award amounts to $7.2 million. The balance of the award was recommended by the National Institutes of Health, which is subject to the availability of funds and satisfactory progress toward the goals of the center. “We are pleased that the National Cancer Institute has recognized the work of our cancer center and has continued to make financing cancer research a high priority,’’ said Frank McCormick, PhD, who has served as director of the UCSF Helen Diller Family Comprehensive Cancer Center since 1997. “Cancer is a devastating disease that takes the life of an American every minute of every day,’’ said McCormick, who is president of the American Association for Cancer Research, a member of the Institute of Medicine, and a Fellow of the Royal Society as well as a scientist actively engaged in cancer research. “Federal support for cancer research is imperative as we move forward with research to save lives in our generation and for future generations.” The Helen Diller Family Comprehensive Cancer Center received the fifth largest amount of funding for its cancer support grant last year among the 67 NCI-designated cancer centers in the United States, according to NCI statistics.
Share Button
Print Friendly

Filed under: Articles

Comments are closed.